Post by Discngine

4,329 followers

π—”π—»π˜π—Άπ—―π—Όπ—±π˜† π—±π—Άπ˜€π—°π—Όπ˜ƒπ—²π—Ώπ˜† π—΅π—Άπ—΄π—΅π—Ήπ—Άπ—΄π—΅π˜π˜€ 𝗳𝗿𝗼𝗺 π—³π—Όπ˜‚π—Ώ π—Άπ—»π—±π˜‚π˜€π˜π—Ώπ˜† π—²π˜ƒπ—²π—»π˜π˜€ 🌟 Collective knowledge-sharing after scientific events helps the field move forward. Our Biologics Solution Lead, MΓ©linΓ© Simsir, has compiled insights from four recent antibody conferences she has attended, bringing together perspectives from experts across the community. The article looks at how the field is progressing across several areas, including ML-based tools, bispecifics and other advanced formats, more systematic validation workflows, and other emerging topics shaping therapeutic antibody research. Read more πŸ‘‰https://bit.ly/3Qe4E0v #antibodydiscovery #antibodyengineering #PEGS #BioLogic #drugdiscovery #biologics

Post content